BioSpace News Archive

The first-in-human Phase 1 study is evaluating the safety and efficacy of DNX-2440 to patients with recurrent glioblastoma for whom surgery is not possible or planned.

Perrigo Company (NYSE; TASE: PRGO) today announced it has received tentative approval from the Food and Drug Administration (FDA) for the first to file generic version of Ultravate® Lotion (halobetasol propionate) 0.05%.

Wharton Research Data Services (WRDS), , is pleased to announce Luzi Hail, Professor of Accounting at the Wharton School of the University of Pennsylvania, David Oesch, Professor of Financial Accounting at the University of Zurich and Maximilian Muhn, Ph.D. candidate at Humboldt University of Berlin as winners of the WRDS Best Paper Award

Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced today that the Food and Drug Administration (FDA)) has approved its investigational new drug (IND) application to conduct a Phase 1 clinical trial in solid tumors with immuno-oncology candidate AVID200, a rationally designed inhibitor of TGF-beta 1 & 3.

To date, there are no known adverse events associated with serious injury or death.

Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories.

Outcome Health, a healthcare innovation company focused on evolving the point-of-care experience, today announced a partnership with the Infectious Diseases Society of America (IDSA) Foundation.

Ambra Health, makers of a leading cloud-based, medical image management suite, today announced a new collaboration with Google Cloud to advance healthcare research with anonymized medical imaging data

Seattle Genetics, Inc. announced today that the company will webcast an investor and analyst event on Monday, December 3, 2018 during the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, Calif.

Mr. Johannessen brings more than 25 years of executive and financial leadership experience in the semiconductor industry, including expertise in operational execution, financial controls, fundraising and international business.